. Author manuscript; available in PMC: 2021 May 1.

Published in final edited form as: Support Care Cancer. 2019 Aug 19;28(5):2205–2215. doi: 10.1007/s00520-019-05031-5

Table 2.

Occurrence Rates for Gastrointestinal Symptoms in the Total Sample (n=1251) and Differences in These Occurrence Rates Between Patients With and Without Chemotherapy-Induced Nausea

Gastrointestinal Symptom	Highest to Lowest Occurrence in Total Sample % (n)	No Nausea 52.8% (n = 660)	Nausea 47.2% (n = 591)	Statistics
Gastrointestinal Symptom	Highest to Lowest Occurrence in Total Sample % (n)	% (n)	% (n)	Statistics
Change in the way food tastes	48.9 (612)	37.7 (249)	61.4 (363)	FE, p < 0.001
Dry mouth	45.6 (570)	33.5 (221)	59.1 (349)	FE, p < 0.001
Constipation	43.2 (541)	32.6 (215)	55.2 (326)	FE, p < 0.001
Lack of appetite	41.3 (517)	24.1 (159)	60.6 (358)	FE, p < 0.001
Feeling bloated	33.1 (414)	24.8 (164)	42.3 (250)	FE, p < 0.001
Diarrhea	29.9 (374)	21.7 (143)	39.1 (231)	FE, p < 0.001
Weight loss	24.9 (312)	16.7 (110)	34.2 (202)	FE, p < 0.001
Abdominal cramps	22.4 (280)	13.5 (89)	32.3 (191)	FE, p < 0.001
Mouth sores	21.3 (267)	15.5 (102)	27.9 (165)	FE, p < 0.001
Difficulty swallowing	13.6 (170)	7.4 (49)	20.5 (121)	FE, p < 0.001
Vomiting	12.7 (159)	1.7 (11)	25.0 (148)	FE, p < 0.001

Abbreviation: FE = Fisher’s Exact test